U.S. market Closed. Opens in 2 hours 50 minutes

LABP | Landos Biopharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
RevenueN/AN/A18.00MN/AN/AN/A
Cost of RevenueN/A577.00K196.00K137.00K103.00KN/A
Gross ProfitN/A-577.00K17.80M-137.00K-103.00KN/A
Operating Expenses22.73M40.56M56.82M30.68M13.29M7.94M
Selling, General & Admin10.73M14.88M15.25M5.34M1.48M1.14M
Research & Development12.00M25.68M41.56M25.34M11.81M6.80M
Other Operating ExpensesN/A1.28M394.00KN/A160.00K2.00M
Operating Income-22.73M-40.56M-38.82M-30.68M-13.29M-7.94M
Other Expenses / Income792.00K1.28M394.00K532.00K-177.00K1.90M
Before Tax Income-21.93M-39.28M-38.42M-30.14M-13.47M-6.04M
Income Tax ExpensesN/A-1.28M-196.00KN/A464.00K1.90M
Net Income-21.93M-37.99M-38.23M-30.14M-13.93M-6.04M
Interest ExpensesN/A-577.00KN/AN/A304.00K4.00K
Basic Shares Outstanding6.28M4.03M4.03M4.01M4.01M2.31M
Diluted Shares Outstanding6.28M4.03M4.03M4.01M4.01M2.31M
EBITDA-22.73M-40.56M-38.82M-30.08M-13.03M-5.85M
EBITDA Margin0.00%0.00%-215.64%0.00%0.00%0.00%
EBIT-21.93M-39.85M-38.42M-30.14M-13.16M-4.14M
EBIT Margin0.00%0.00%-213.46%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙